$SNA

on (NYSE:SNA) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

Snap-on (NYSE: SNA) reported Q2 CY2026 revenue of $1.24 billion, down 3.6% year on year and below Wall Street estimates, according to the article. GAAP EPS was $4.96, up from $4.72 and described as in line with consensus. Analysts expect revenue to rise about 5% over 12 months and full-year EPS to increase from $19.60 to $20.53.

Original reporting
Published Jul 23, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 1:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
on (NYSE:SNA) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings — source image
Decision brief

The 30-second read

$SNANeutralMed
01

Why it matters

Revenue missed expectations and declined 3.6% YoY, while operating margin rose to 27.2% and EPS of $4.96 was close to consensus; the net effect is a mixed earnings quality signal.

02

Market read

Traders can reassess near-term demand expectations and the durability of margin-driven EPS support after the Q2 print and the stated 12-month revenue growth expectation.

03

What to watch

The article does not quantify guidance details, backlog, order trends, or segment performance, so the revenue miss may be driven by timing or mix rather than structural deterioration.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session reaction to Q2 CY2026 results and the stated 12-month revenue outlook

Background

The piece frames Snap-on’s Q2 CY2026 results versus analyst expectations, highlighting revenue decline, organic revenue flatness, and profitability trends.

Company-level read

Ticker impact

$SNANeutralMedium confidence
Context

Snap-on reported Q2 CY2026 revenue of $1.24B, down 3.6% YoY, missing Wall Street’s revenue expectations while EPS of $4.96 was near consensus.

Expected impact

Likely choppy trading, with downside risk if investors focus on the revenue decline versus the margin and EPS support.

Evidence & confidence

The article provides a concrete Q2 revenue miss and YoY decline, plus offsetting operating margin expansion and EPS near estimates, which typically reduces directional conviction.

Market effects

Signals continued demand softness in industrial tools and diagnostics, with investors watching whether margin resilience can offset top-line weakness.

No specific regional demand or macro driver is provided in the article.

No explicit global supply-chain or international demand shock is disclosed beyond organic revenue being flat.

Counterpoint

Investors may treat the operating margin expansion and EPS support (including share count shrink) as evidence that earnings quality is improving even if revenue growth is muted.

Key entities

  • Snap-on

    Tools, equipment, and diagnostics provider reporting Q2 CY2026 results with a revenue miss and margin expansion.

Related articles

$SNAMed

What's Going On With Snap-on Stock on Thursday? - Snap-on (NYSE:SNA)

Snap-on (NYSE:SNA) reported diluted EPS of $4.96 vs $4.95 estimate and net sales up 4.7% to $1.235B vs $1.220B, with 3% organic growth and gross margin improving to 51.4% from 50.5%. Operating cash flow rose to $271.5M. The company completed acquisitions of Hi-Force and Diesel Laptops and expects about $100M capex in 2026.

$SNAMed

Snap-on Inc (SNA): Results of Operations and Financial Condition

Snap-on Inc (SNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q22026pressreleaseforpress.htm EX-99 Document Exhibit 99 Snap-on Announces Second Quarter 2026 Results Sales of $1,235.1 million up 4.7% from Q2 2025, organic sales up 3.0%; Gross margin of 51.4% compares to 50.5% a year ago; Diluted EPS of $4.96 for the quarter compares

$MATVMed

Mativ Q2 Earnings Call Highlights

Mativ (NYSE:MATV) reported Q2 adjusted EBITDA of $50 million, up more than 18%, and segment margin up 210 bps to 15.3% as pricing offset inflation. Healthcare operations at its Knoxville facility normalized after an outage. Net debt fell to $908 million and net leverage improved to 3.8x. A Menasha, Wisconsin tornado is expected to cut Q3 sales by $20M to $25M.

$MAINMed

Main Street Capital Q2 Earnings Call Highlights

Main Street Capital (NYSE:MAIN) reported Q2 results on an earnings call. Total investment income was $149.6M (+3.9% YoY, +6.8% QoQ). DNII before taxes was $1.08/share; CFO expects at least $0.97/share in Q3. The board declared a $0.30 supplemental dividend and regular monthly dividends of $0.265/share. MAIN invested about $100M in lower middle market deals and $239M in private loans.

$LTMMedAI 8/10

LATAM Airlines Group Q2 Earnings Call Highlights

LATAM Airlines Group reported Q2 net income of $125 million and adjusted operating cash flow of $476 million, with nearly $150 million positive cash change before dividends. The company said premium revenue was 29% of passenger revenue and LATAM Pass generated over 67% of passenger revenue. It reinstated 2026 guidance: revenue $17.3B to $17.7B and adjusted EBITDA $4.1B to $4.4B, plus 9% to 10% capacity growth.

$MAGNMed

Magnera Q3 Earnings Call Highlights

Magnera (NYSE:MAGN) reported Q3 updates on infrastructure and filtration-related sales, with Americas revenue essentially flat year over year. Adjusted EBITDA rose 16% to $71 million in the Americas. The company reaffirmed full-year free cash flow of about $90M to $110M, but expects full-year adjusted EBITDA toward the low end of its prior range, citing inflation and macro uncertainty.